Antagoniste


21 mai 2010

Rand Paul à raison Économie États-Unis Hétu Watch

Free Banking

Richard Hétu est au bord de la crise d’apoplexie ! Depuis hier, il multiplie les billets sur Rand Paul parce ce dernier ne croit pas que le gouvernement fédéral a le droit d’imposer des lois anti-discriminations à des entreprises privées. Si Richard Hétu n’était pas un parfait illettré économique, il aurait déjà réalisé que Rand Paul a raison sur toute la ligne.

Pour l'économiste Gary Becker (prix Nobel d'économie en 1992), les lois anti-discriminations en milieu de travail sont inutiles, le meilleur moyen pour éliminer les les préjugés étant de laisser le libre-marché faire son oeuvre.

Russ Roberts et Bryan Caplan (George Mason University) expliquent la théorie de Becker:

Clip audio : Le lecteur Adobe Flash (version 9 ou plus) est nécessaire pour la lecture de ce clip audio. Téléchargez la dernière version ici. Vous devez aussi avoir JavaScript activé dans votre navigateur.


21 mai 2010

Moment historique États-Unis Revue de presse

The New York Times

Researchers Say They Created a ‘Synthetic Cell’
The New York Times

The genome pioneer J. Craig Venter has taken another step in his quest to create synthetic life, by synthesizing an entire bacterial genome and using it to take over a cell.

Dr. Venter calls the result a “synthetic cell” and is presenting the research as a landmark achievement that will open the way to creating useful microbes from scratch to make products like vaccines and biofuels. At a press conference Thursday, Dr. Venter described the converted cell as “the first self-replicating species we’ve had on the planet whose parent is a computer.”

Dr. Venter’s aim is to achieve total control over a bacterium’s genome, first by synthesizing its DNA in a laboratory and then by designing a new genome stripped of many natural functions and equipped with new genes that govern production of useful chemicals.

The cost of the project was $40 million, most of it paid for by Synthetic Genomics, a company Dr. Venter founded.

But the bacterium used by the Venter group is unsuitable for biofuel production, and Dr. Venter said he would move to different organisms. Synthetic Genomics has a contract from Exxon to generate biofuels from algae. Exxon is prepared to spend up to $600 million if all its milestones are met. Dr. Venter said he would try to build “an entire algae genome so we can vary the 50 to 60 different parameters for algae growth to make superproductive organisms.”